Sign in Subscribe
Pharmaceutical industry

Top Biotech and Pharmaceutical Companies Revealed by GEN

Strategic Insights

— 1 min read

As reported by Genetic Engineering News (www.genengnews.com), Amgen (AMGN:NASDAQ) has topped the list of the "Top 50 Biotech Companies" with a market capitalization of $93.09 billion as of this year. This impressive number is a testament to the company's success in transitioning from a young research boutique to a pharmaceutical firm. Meanwhile, Pfizer (PFE:NYSE) comes in first among the "Top 10 Pharmaceutical Firms" with a market capitalization of $193.57 billion.

Key Takeaways:

  • Amgen leads the list of the "Top 50 Biotech Companies" with a market capitalization of $93.09 billion, representing a 28.4% increase from last year.
  • Genentech comes in second with a market capitalization of $89.53 billion, growing by 17% from last year.
  • Amgen and Genentech have market caps greater than five of the top 10 traditional pharmaceutical companies, including Johnson and Johnson, GlaxoSmithKline, and Merck and Co.
  • The top 10 pharmaceutical firms, excluding Pfizer, include Johnson and Johnson, GlaxoSmithKline, Sanofi Aventis, Novartis, Merck and Co., AstraZeneca, Abbott Labs, Wyeth, and Eli Lilly and Co.
  • Biogen Idec, Gilead Sciences, Genzyme, and Biogen Idec also make the list of top biotech companies.
  • The April issue of GEN, which includes the complete list of the top 50 biotech firms, is available upon request by calling 914-740-2122 or emailing ebicovny@liebertpub.com.

Statistics:

  • Amgen's market capitalization increased by 28.4% from last year to $93.09 billion.
  • Genentech's market capitalization grew by 17% from last year to $89.53 billion.
  • Pfizer's market capitalization is $193.57 billion, making it the largest among the top 10 pharmaceutical firms.
  • Johnson and Johnson has a market capitalization of $171.53 billion, ranking second among the top 10 pharmaceutical firms.
  • The top 10 pharmaceutical firms, excluding Pfizer, have a combined market capitalization of $717.72 billion.

Sources:

  • Genetic Engineering News (www.genengnews.com)
  • GEN (www.genengnews.com)
  • Mary Ann Liebert, Inc. (www.liebertpub.com)

Read more